![\"Atomic](\"https:\/\/www.tomgrimshaw.com\/tomsblog\/wp-content\/uploads\/2025\/10\/Atomic_Structure.jpg\")
<\/p>\n<\/p>\n
The chemical used in the Trump administration\u2019s new \u2018Generation Gold Standard<\/a>\u2019 bird flu vaccine platform\u2014beta-propiolactone (BPL)\u2014is classified as a \u2018Group 2B\u2019 carcinogen by U.S. regulators (meaning the substance is possibly cancer-causing in humans) and as a \u2018Group 1B\u2019 carcinogen in Europe (meaning it\u2019s presumed to cause cancer in humans).<\/p>\n A carcinogen<\/a> is any substance or agent capable of causing cancer by damaging a cell\u2019s DNA and leading to uncontrolled cell growth.<\/p>\n The revelation follows this website\u2019s report<\/a> that the U.S. National Institute of Allergy and Infectious Diseases (NIAID)\u2014under Dr. Jeffery Taubenberger\u2019s direction\u2014has been funding the creation of chimeric, lab-engineered bird flu viruses in American and foreign laboratories, even as Taubenberger himself is named on a federal patent for the very BPL-utilizing bird flu vaccine platform those experiments are designed to justify.<\/p>\n A May 2025 government press release<\/a> announced the multi-million dollar BPL platform will be used to generate bird flu pandemic vaccines:<\/p>\n The U.S. Department of Health and Human Services (HHS) and the National Institutes for Health (NIH) today announced the development of the next-generation, universal vaccine platform, Generation Gold Standard, using a beta-propiolactone (BPL)-inactivated, whole-virus platform.<\/p>\n This initiative represents a decisive shift toward transparency, effectiveness, and comprehensive preparedness, funding the NIH\u2019s in-house development of universal influenza and coronavirus vaccines, including candidates BPL-1357 and BPL-24910. These vaccines aim to provide broad-spectrum protection against multiple strains of pandemic-prone viruses like H5N1 avian influenza and coronaviruses including SARS-CoV-2, SARS-CoV-1, and MERS-CoV.<\/p><\/blockquote>\n